Epimedokoreanin B structure
|
Common Name | Epimedokoreanin B | ||
---|---|---|---|---|
CAS Number | 161068-53-7 | Molecular Weight | 422.470 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 665.9±55.0 °C at 760 mmHg | |
Molecular Formula | C25H26O6 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 228.2±25.0 °C |
Use of Epimedokoreanin BEpimedokoreanin B is a natural flavonoid with anticancer, anti-inflammatory and antibacterial effects. Epimedokoreanin B inhibits the growth of lung cancer cells through endoplasmic reticulum stress-mediated Apoptosis accompanied by autophagosome accumulation. Epimedokoreanin B is an anti-periodontitis agent that inhibits gingipains and Porphyromonas gingivalis growth and biofilm formation[1][2][3]. |
Name | Epimedokoreanin B |
---|---|
Synonym | More Synonyms |
Description | Epimedokoreanin B is a natural flavonoid with anticancer, anti-inflammatory and antibacterial effects. Epimedokoreanin B inhibits the growth of lung cancer cells through endoplasmic reticulum stress-mediated Apoptosis accompanied by autophagosome accumulation. Epimedokoreanin B is an anti-periodontitis agent that inhibits gingipains and Porphyromonas gingivalis growth and biofilm formation[1][2][3]. |
---|---|
Related Catalog | |
In Vitro | Epimedokoreanin B (compound6; 3.13-25 μM; 48 hours) 对肺癌细胞 A549、Calu1 和 H1299 的增殖显示出显着的抑制作用。Epimedokoreanin B 对人支气管上皮细胞 BEAS-2B 无毒性[1]。 Epimedokoreanin B 处理抑制 A549 和 NCI-H292 细胞中伴随细胞质空泡形成的细胞增殖和迁移。Epimedokoreanin B 处理的细胞中观察到自噬体聚集并伴有自噬通量阻断,这与内质网应激的发生相符[2]。 Epimedokoreanin B(5 μM;24 小时)抑制 CD163 表达和 IL-10 的产生,这是已知的 M2 标记,表明 Epimedokoreanin B 抑制人单核细胞衍生巨噬细胞 (HMDM) 中的 M2 极化。Epimedokoreanin B 抑制 HMDMs 中的 STAT3 激活[4]。 Cell Cytotoxicity Assay[1] Cell Line: A549, Calu1 and H1299 cells Concentration: 3.13 μM, 6.25 μM, 12.5 μM and 25.0 μM Incubation Time: 48 hours Result: Showed significate inhibitory effect on proliferation against lung cancer cell A549, Calu1 and H1299. Western Blot Analysis[4] Cell Line: Human monocyte-derived macrophages (HMDMs) Concentration: 5 μM Incubation Time: 24 hours Result: Significantly suppressed IL-10-induced JAK1/STAT3 activation.and H1299. |
In Vivo | Epimedokoreanin B(20 mg/kg;口服;每周三次;持续 17 天)抑制 LM8 荷瘤鼠模型中的肿瘤生长[4]。 Animal Model: Female C3H mice (8-10 weeks old) injected with LM8 cells[4] Dosage: 20 mg/kg Administration: Oral administration; thrice a week; for 17 days Result: Inhibited tumor growth. |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 665.9±55.0 °C at 760 mmHg |
Molecular Formula | C25H26O6 |
Molecular Weight | 422.470 |
Flash Point | 228.2±25.0 °C |
Exact Mass | 422.172943 |
PSA | 111.13000 |
LogP | 6.59 |
Vapour Pressure | 0.0±2.1 mmHg at 25°C |
Index of Refraction | 1.650 |
2-(3,4-Dihydroxy-5-((E)-3-methyl-but-2-enyl)-phenyl)-5,7-dihydroxy-8-(3-methyl-but-2-enyl)-1-benzopyran-4-one |
2-[3,4-Dihydroxy-5-(3-methyl-2-buten-1-yl)phenyl]-5,7-dihydroxy-8-(3-methyl-2-buten-1-yl)-4H-chromen-4-one |
2-[3,4-Dihydroxy-5-((E)-3-methyl-but-2-enyl)-phenyl]-5,7-dihydroxy-8-(3-methyl-but-2-enyl)-1-benzopyran-4-one |
4H-1-Benzopyran-4-one, 2-[3,4-dihydroxy-5-(3-methyl-2-buten-1-yl)phenyl]-5,7-dihydroxy-8-(3-methyl-2-buten-1-yl)- |